Treatment and Care
Treatment Centers and Clinical Services
Care Team
Patient And Family Support
Care Quality and Patient Safety
Patient Stories
For Adult Cancer Survivors
Browse by Cancer Type
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

New Patient Guide

Appointments & Second Opinions

New Patient? For appointments or second opinions: Adults: (877) 442-DFCI (442-3324) Children: (888) PEDI-ONC (733-4662) or complete the Appointment Request Form Online Specialty Consultations International Patients Referring Physician? To refer an adult patient: (877) 441-DFCI (441-3324) To refer a pediatric patient: (888) PEDI-ONC (733-4662) or complete the Patient Referral Form

Treatment and Care

Pediatric Treatment Centers and Clinical Services Care Team Patient And Family Support Care Quality and Patient Safety Patient Stories For Survivors of Childhood Cancer Browse by Cancer Type A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

New Patient Guide

Appointments & Second Opinions

New Patient? For appointments or second opinions: Adults: (877) 442-DFCI (442-3324) Children: (888) PEDI-ONC (733-4662) or complete the Appointment Request Form Your Child's Care Team For International Patients Referring Physician? To refer an adult patient: (877) 441-DFCI (441-3324) To refer a pediatric patient: (888) PEDI-ONC (733-4662) or complete the Patient Referral Form

Home
Newsroom
In The News

In The News

Search In The News

Date Range

From:

To:

clear all

Archives

Email
Print
Share
Text

Highlight Glossary Terms

News tagged ‘Antibody’ clear

Sorted by:
Date
Title

ASH 2012 Multiple Myeloma Update – Day Three: Early Morning Oral Session (Myeloma Beacon)
- December 10, 2012

At the American Society of Hematology's annual meeting, Dr. Nikhil Munshi presented results from a study of the antibody BHQ880, which targets DKK-1, a protein that inhibits bone formation and is overabundant in people with multiple myeloma.

Tags: Antibody, BasicResearch, MultipleMyeloma

Showing 1-1 of 1 items